entertainment -WSS

entertainment

author：leisure time 2025-09-27 19:49:54 - browse：674

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Secretariat’s lessons for human medicine

WSS

Secretariat’s lessons for human medicine

Timeline: Special counsel's probe into Trump's handling of classified documents

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

FDA warns medical device makers about rise in fabricated data

Flagship Pioneering startup Sonata Therapeutics lays off 21

focus

entertainment

explore

At least 13 dead in Texas as scorching temps continue

CDC: Cases of alpha

In age of alternative facts, a scholarly course on calling out crap

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

DIEP, the 'gold standard' of breast reconstruction, is under threat

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Alkermes shareholders re

Timeline: Special counsel's probe into Trump's handling of classified documents

23andMe had bad news about my health. I wish a person had delivered it

In 'major milestone,' FDA approves first cell therapy for solid tumors

hotspot

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Ending health disparities requires full federal government, panel says

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Secretariat’s lessons for human medicine

'The boss' wants server deleted: New allegations emerge in Trump indictment

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

leisure time

leisure time

Wikipedia

focus